Predicting benefit from maintenance durvalumab after firstline chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA-based assay
dc.contributor.author | Fong, C. Y. K. | |
dc.contributor.author | Iyer, S. | |
dc.contributor.author | Potts, L. | |
dc.contributor.author | Peckitt, C. | |
dc.contributor.author | Cromarty, S. | |
dc.contributor.author | Saffery, C. | |
dc.contributor.author | Kidd, S. | |
dc.contributor.author | Rana, T. | |
dc.contributor.author | Ausec, L. | |
dc.contributor.author | Gregorc, A. | |
dc.contributor.author | Pointing, D. | |
dc.contributor.author | Gombert, M. | |
dc.contributor.author | Von Loga, K. | |
dc.contributor.author | Benjamin, L. | |
dc.contributor.author | Starling, N. | |
dc.contributor.author | Waddell, Thomas | |
dc.contributor.author | Petty, R. | |
dc.contributor.author | Uhlik, M. | |
dc.contributor.author | Chau, I. | |
dc.contributor.author | Cunningham, D. | |
dc.date.accessioned | 2023-01-24T10:32:24Z | |
dc.date.available | 2023-01-24T10:32:24Z | |
dc.date.issued | 2022 | en |
dc.identifier.citation | Fong CYK, Iyer S, Potts L, Peckitt C, Cromarty S, Saffery C, et al. Predicting benefit from maintenance durvalumab after firstline chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA-based assay. Annals of Oncology. 2022 Sep;33(7):S1110-S. PubMed PMID: WOS:000866211601487. | en |
dc.identifier.doi | 10.1016/j.annonc.2022.07.1344 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625968 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.annonc.2022.07.1344 | en |
dc.title | Predicting benefit from maintenance durvalumab after firstline chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA-based assay | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Gastrointestinal/Lymphoma Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK; | en |
dc.identifier.journal | Annals of Oncology | en |
dc.description.note | en] |